| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1fefd66fdbc3870bbaa8e5a4f87bdb0a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0057
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0042 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N1-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2020-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f12d2393d287e670a22cad391d761ff1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fa7922d51b7e9381d6cdb6eba6ffb31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c87fbd42957bd10bc76d1642aefb9755
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30495cde47c5999601b19ff7b55141e3 |
| publicationDate |
2021-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-112451684-A |
| titleOfInvention |
A kind of light transparent agent and preparation method thereof |
| abstract |
The invention relates to the technical field of biological imaging, in particular to a light transparent agent and a preparation method thereof. The light transparent agent includes a first component and a second component; wherein: the first component is composed of PEG400 and glycerol with a volume ratio of (0.2-5.0): 1; the second component is thionone ; The volume ratio of the first component to the second component is (1-50):1. In the present invention, the optical clearing agent obtained by selecting specific components and compounding in a specific ratio can reduce the degree of light scattering by the tissue. Compared with other optical clearing agents in the prior art, the optical clearing agent of the present invention has Tissue penetration is greater. |
| priorityDate |
2020-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |